ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ELOX Eloxx Pharmaceuticals Inc

3.82
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Eloxx Pharmaceuticals Inc NASDAQ:ELOX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.82 3.60 3.75 0 01:00:00

Additional Proxy Soliciting Materials (definitive) (defa14a)

29/04/2022 9:23pm

Edgar (US Regulatory)



 UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549


 
SCHEDULE 14A INFORMATION
 
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
 

 
Filed by the Registrant             Filed by a Party other than the Registrant  
 
Check the appropriate box:

Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under § 240.14a-12

Eloxx Pharmaceuticals, Inc.

(Name of Registrant as Specified In Its Charter)


(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
 
Payment of Filing Fee (Check all boxes that apply):
 
 
No fee required
Fee paid previously with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11








1 Year Eloxx Pharmaceuticals Chart

1 Year Eloxx Pharmaceuticals Chart

1 Month Eloxx Pharmaceuticals Chart

1 Month Eloxx Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock